Metraipolis › archive › dc_352650909eb5
Neurological and hematological safety profiles of GSK-3β inhibitors: insights from multi-database pharmacovigilance and experimental validation — Europe PMC PMID:42824466
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42824466
- DOI
- 10.3389/fimmu.2026.1915614
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T14:45:05.739Z
- SHA-256 of the archived text
6945cea26e030c703006a4323aa55a948456a800be480a51277e16c2826be40d- Stable URL of this page
https://metraipolis.com/documento/dc_352650909eb5
How to cite
Neurological and hematological safety profiles of GSK-3β inhibitors: insights from multi-database pharmacovigilance and experimental validation — Europe PMC PMID:42824466 — Europe PMC (en), https://europepmc.org/article/MED/42824466 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_352650909eb5 (Metraipolis archive dc_352650909eb5, sha256 6945cea26e030c703006a4323aa55a948456a800be480a51277e16c2826be40d)
BibTeX
@misc{dc352650909eb5,
title = {Neurological and hematological safety profiles of GSK-3β inhibitors: insights from multi-database pharmacovigilance and experimental validation — Europe PMC PMID:42824466},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42824466},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_352650909eb5; sha256 6945cea26e030c703006a4323aa55a948456a800be480a51277e16c2826be40d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824466. Agents can read the archived copy with the MCP tool read_document.